Technical Analysis for CLIN - Clinigen Group Plc

Grade Last Price % Change Price Change
C 832.5 1.46% 12.00
CLIN closed up 1.46 percent on Friday, April 9, 2021, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical CLIN trend table...

Date Alert Name Type % Chg
New Uptrend Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Pocket Pivot Bullish Swing Setup 1.46%
Upper Bollinger Band Walk Strength 1.46%
Above Upper BB Strength 1.46%
Older End-of-Day Signals for CLIN ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Clinigen Group Plc Description

Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources commercial medical products for use in clinical studies, including comparator drugs, adjuvant drugs and rescue therapies; Idis Managed Access (MA), which is engaged in the consultancy, development, management and implementation of managed access programs for biotechnology and pharmaceutical companies; Idis Global Access (GA), which offers ethical access to post approval and short-supply medicines; Clinigen Specialty Pharmaceuticals (SP), which manufactures and distributes its own and in-licensed specialist, hospital-only medicines around the world, and Link Healthcare, which distributes pharmaceutical products in South Africa, and the Asia and Pacific region.


Sector: Healthcare
Industry: Medical Distribution
Keywords: Health Healthcare Pharmaceutical Consultancy Biotechnology Medicine Clinic Pharmaceuticals Hospital Drugs Clinical Trial Pharmaceutical Industry Therapies Rescue Clinical Research Pharmaceutical Products Medication Pharmaceutical Industry In China Pharmaceutical Companies Pharmaceuticals Policy Medical Products Design Of Experiments Idis Clinical Trial Services

Is CLIN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 940.0
52 Week Low 515.0
Average Volume 326,232
200-Day Moving Average 697.54
50-Day Moving Average 748.74
20-Day Moving Average 762.48
10-Day Moving Average 783.75
Average True Range 25.32
ADX 26.67
+DI 29.73
-DI 9.18
Chandelier Exit (Long, 3 ATRs ) 756.55
Chandelier Exit (Short, 3 ATRs ) 748.45
Upper Bollinger Band 827.53
Lower Bollinger Band 697.42
Percent B (%b) 1.04
BandWidth 17.06
MACD Line 22.61
MACD Signal Line 14.40
MACD Histogram 8.2055
Fundamentals Value
Market Cap 1.11 Billion
Num Shares 133 Million
EPS 10.20
Price-to-Earnings (P/E) Ratio 81.62
Price-to-Sales 1.72
Price-to-Book 1.92
PEG Ratio 0.00
Dividend 0.08
Dividend Yield 0.01%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 859.50
Resistance 3 (R3) 856.50 844.50 855.00
Resistance 2 (R2) 844.50 837.62 846.00 853.50
Resistance 1 (R1) 838.50 833.38 841.50 841.50 852.00
Pivot Point 826.50 826.50 828.00 828.00 826.50
Support 1 (S1) 820.50 819.62 823.50 823.50 813.00
Support 2 (S2) 808.50 815.38 810.00 811.50
Support 3 (S3) 802.50 808.50 810.00
Support 4 (S4) 805.50